The added value of H2 antagonists in premedication regimens during paclitaxel treatment
Juul M. Cox, Leni van Doorn, Ruben Malmberg, Esther Oomen‐de Hoop, Tessa M. Bosch, Patricia M. L. A. van den Bemt, Ingrid Boere, Agnes Jager, Ron H.J. Mathijssen, Roelof W. F. van Leeuwen
Topics & Concepts
RanitidinePremedicationRegimenMedicineAnesthesiaConfidence intervalSurgeryInternal medicineDrug-Induced Adverse ReactionsMast cells and histamineAsthma and respiratory diseases